Achillion Pharmaceuticals Inc

$ 2.640
Updated 14/08/2018
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 135,562
High $ 2.690
Low $ 2.610
Open $ 2.680
Prev close $ 2.670
# of shares 138.59M
Market cap 365.87M USD

Market closed
Achillion Pharmaceuticals Inc
Market is closed, opens at 14:30
Price development Latest 1 week 1 month 3 months 6 months 1 year
  2.64 5.2% Stock price increasing -15.9% Stock price decreasing -25.8% Stock price decreasing -14.0% Stock price decreasing -47.2% Stock price decreasing
Powered by TradingView

News about Achillion Pharmaceuticals Inc

  • English
  • Regulatory news

Company profile

Achillion Pharmaceuticals Inc is a biotechnology company that seeks to discover and commercialize treatments for rare diseases. The company is engaged solely in the discovery and development of innovative small-molecule drug therapies for infectious diseases and immune system disorders. Achillion specializes in structural biology, medicinal chemistry, and antimicrobial discovery research. The company generates revenue from product sales, regulatory and commercialization milestones, and royalties. Achillion also uses collaborative and licensing agreements.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
15 August 2018 11:46:47
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180815.2 - EUROWEB6 - 2018-08-15 12:46:47 - 2018-08-15 11:46:47 - 1000 - Website: OKAY